Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -105.4%
- Revenue declining 38% annually
DNA X, Inc. - Common Stock (SONM) is a Technology company operating in Telephone & Telegraph Apparatus, listed on the NASDAQ , with a market capitalisation of $4 million . Key value metrics: Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
DNA X, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, SONM shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -105.4% (sector average: -3.1%), and minimal leverage with a debt-to-equity ratio of 0.01.
StockPik's composite Value Score for SONM is 45/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SONM reports a moderate gross margin of 25.8% (sector average: 41.3%) and a negative operating margin of -21.0%.
SONM shows revenue declining at 38% year-over-year, with earnings declining at 37,287%.